A detailed history of Fmr LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,320,435 shares of TNYA stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,320,435
Previous 2,910,126 54.63%
Holding current value
$3.3 Million
Previous $15.2 Million 73.11%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.72 - $4.99 $4.32 Million - $7.93 Million
-1,589,691 Reduced 54.63%
1,320,435 $4.09 Million
Q1 2024

May 13, 2024

BUY
$2.88 - $6.8 $735,480 - $1.74 Million
255,375 Added 9.62%
2,910,126 $15.2 Million
Q4 2023

Feb 13, 2024

SELL
$1.73 - $3.39 $920,360 - $1.8 Million
-532,000 Reduced 16.69%
2,654,751 $8.6 Million
Q3 2023

Nov 13, 2023

SELL
$2.55 - $5.65 $1.45 Million - $3.21 Million
-567,488 Reduced 15.12%
3,186,751 $8.13 Million
Q2 2023

Aug 11, 2023

SELL
$2.64 - $7.64 $15,990 - $46,275
-6,057 Reduced 0.16%
3,754,239 $22 Million
Q1 2023

May 11, 2023

BUY
$1.92 - $3.59 $1.79 Million - $3.34 Million
929,820 Added 32.85%
3,760,296 $10.7 Million
Q4 2022

Feb 13, 2023

SELL
$1.68 - $3.19 $495,300 - $940,482
-294,822 Reduced 9.43%
2,830,476 $5.69 Million
Q3 2022

Nov 10, 2022

SELL
$2.9 - $5.88 $6.97 Million - $14.1 Million
-2,403,744 Reduced 43.47%
3,125,298 $9.06 Million
Q2 2022

Aug 12, 2022

SELL
$5.01 - $14.12 $3.32 Million - $9.36 Million
-662,966 Reduced 10.71%
5,529,042 $31.1 Million
Q1 2022

May 13, 2022

BUY
$9.41 - $19.3 $4.41 Million - $9.04 Million
468,276 Added 8.18%
6,192,008 $72.9 Million
Q4 2021

Feb 14, 2022

BUY
$18.41 - $29.58 $11.4 Million - $18.3 Million
620,255 Added 12.15%
5,723,732 $107 Million
Q3 2021

Nov 15, 2021

BUY
$15.35 - $26.66 $78.3 Million - $136 Million
5,103,477 New
5,103,477 $105 Million

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $103M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.